Emmaus Life Sciences ( Emmaus Life Sciences)

Primary tabs

Emmaus Life Sciences's picture

Management

Contact Address

About Emmaus Life Sciences

The mission of Emmaus Life Sciences is to improve the lives of people with rare disease by the discovery, development and commercialization of innovative treatments and therapies for rare and orphan diseases.

Emmaus Life Sciences press release, blog etc

Thu, 06/26/2025 - 21:57 Emmaus Life Sciences Receives FDA Approval for Endari Label Enhancements
Wed, 01/29/2025 - 12:22 Emmaus Life Science Reports Grant of Endari Market Exclusivity In Kingdom of Saudi Arabia
Tue, 07/23/2024 - 14:27 Emmaus Life Sciences Announces Willis C. Lee as Chief Executive Officer
Sun, 07/14/2024 - 05:53 Emmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance Program
Mon, 12/19/2022 - 19:24 Dr. Niihara Meets with Local Indian Governor
Mon, 12/19/2022 - 00:51 Dr. Niihara Feted by Indian Government in Recognition of the Development of Endari
Wed, 12/07/2022 - 07:17 Endari Receives Kuwaiti Marketing Authorization
Thu, 11/17/2022 - 11:40 Emmaus Life Sciences Receives Endari Marketing Authorization from the Qatar Ministry of Public Health
Sun, 11/13/2022 - 21:09 Emmaus Life Sciences Reports Q3 2022 Financial Results and Provides Business Update
Wed, 09/28/2022 - 17:11 Emmaus Life Sciences Announces Collaboration with Kier (Junior) Spates to Share Personal Experience with Sickle Cell Disease and Endari
Mon, 08/15/2022 - 01:09 Emmaus Life Sciences Reports Q2 2022 Financial Results and Provides Business Update
Wed, 06/22/2022 - 07:22 Life Sciences Investor Forum: Company Executives Present Live
Mon, 05/02/2022 - 21:25 Emmaus Life Sciences Reports Q1 2022 Financial Results and Provides Business Update
Tue, 03/29/2022 - 14:09 Emmaus Life Sciences Announces Endari To Be Added to the Florida Medicaid Preferred Drug List
Tue, 03/22/2022 - 23:24 Emmaus Life Sciences Receives U.A.E. Marketing Authorization for Endari
Fri, 03/04/2022 - 09:43 Emmaus Life Sciences Real World Data on Endari Accepted for E-Poster at the 62nd Annual Scientific Meeting of the British Society for Haematology
Tue, 01/04/2022 - 04:24 Emmaus Life Sciences to Present at the H.C. Wainwright BioConnect Conference
Fri, 12/31/2021 - 11:27 Emmaus Life Sciences Reports 2021 Financial Results and Provides Business Update